Cardiff Oncology Inc (CRDF)

EBITDA Growth

22.78%

TTM · Period ending:

CRDF logo

CRDF EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported22.78%
CRDF TTM EBITDA YoY % (-6.26% → 22.78%)
High-resolution chart · PNG

CRDF ebitda growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Cardiff Oncology Inc EBITDA Growth — Trailing twelve months (TTM)
Period endingEBITDA Growth
22.7817%
9.786%
0.7773%
-15.9854%
-24.5425%
-21.3592%
-9.7069%
-5.3191%
-2.9374%
-3.0539%
-6.6939%
-4.4283%
-6.1239%
-16.1656%
-39.2608%
-52.5483%
-62.2363%
-65.0151%
-46.6271%
-113.6663%
-94.848%
-70.5121%
-61.6882%
25.8605%
24.3733%
20.6774%
25.3077%
-9.8011%
-3.2279%
14.2173%
25.4217%
43.2209%
52.3%
50.6548%
44.1239%
30.4242%
6.1741%
-15.7453%
-50.3672%
-67.2567%
-61.9772%
-101.3157%
-83.9132%
-85.4976%
-82.6664%
3.1867%
-0.3167%
46.6771%
40.3578%
-4.0753%
10.3965%
-418.6818%
-374.0995%
-340.3284%
-407.6365%
-33.1498%
37.4257%
44.2392%
46.1612%
46.2552%
-67.4161%
-76.2095%
62.7718%
31.5825%
-6.2592%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.